US EditionPublished • loading... • Updated
Agios Pharmaceuticals (NASDAQ:AGIO) Upgraded at Wall Street Zen
Summary by themarketsdaily.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Agios Pharmaceuticals (NASDAQ:AGIO) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of Agios Pharmaceuticals (NASDAQ:AGIO – Free Report) from a sell rating to a hold rating in a research report sent to investors on Saturday. A number of other brokerages also recently commented on AGIO. HC Wainwright upped their target price on Agios Pharmaceuticals from $62.00 to $65.00 and gave the […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
